Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Accord Adds To Oncology Offering With Orgovyx
Deal For Prostate Cancer Drug Follows Camcevi Leuprolide Launch In US
May 11 2022
•
By
David Wallace
Accord has struck a deal with Myovant Sciences for prostate cancer drug Orgovyx • Source: Shutterstock
More from Deals
More from Business